SEARCH

SEARCH BY CITATION

References

  • 1
    d'Arminio Monforte A, Cinque P, Mocroft A et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004; 55: 320328.
  • 2
    Carson KR, Evens AM, Richey EA et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009; 113: 48344840.
  • 3
    Royal W 3rd, Dupont B, McGuire D et al. Topotecan in the treatment of acquired immunodefi ciency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 2003; 9: 411419.
  • 4
    Hall CD, Dafni U, Simpson D et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodefi ciency virus infection. N Engl J Med 1998; 338: 13451351.
  • 5
    De Luca A, Ammassari A, Pezzotti P et al. Cidofovir in addition to antiretroviral treatment is not eff ective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 2008; 22: 17591767.
  • 6
    Geschwind MD, Skolasky RI, Royal WS, McArthur JC. The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J Neurovirol 2001; 7: 353357.
  • 7
    Ath A, Venkataramana A, Reich DS, Cortese I, Major EO. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology 2006; 66: 149150.
  • 8
    Cettomai D, McArthur JC. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 2009; 66: 255258.
  • 9
    Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd. Impact of HAART AND CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 2009; 23: 18931901.
  • 10
    Marra CM, Zhao Y, Clifford DB et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 2009; 23: 13591366.
  • 11
    Lanoy E, Guiguet M, Bentata M et al. Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score. Neurology 2011; 76: 644651.
  • 12
    Gasnault J, Lanoy E, Bentata M, Guiguet M, Costagliola D. Intracerebral penetrating ART are more effi cient on survival of HIV+ patients with progressive multifocal leucoencephalopathy (ANRS CO4—FHDH). 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 2008 [Abstract 385].
  • 13
    Gasnault J, Costagliola D, Hendel-Chavez H et al. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One 2011; 6: e20967.
  • 14
    Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4: 5968.
  • 15
    Letendre S, Marquie-Beck J, Capparelli E et al. Validation of the CNS penetration-eff ectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65: 6570.
  • 16
    Letendre S, Ellis R, Deutsch R et al. Correlates of Time-to-Loss-of-Viral-Response in CSF and Plasma in the CHARTER Cohort. CROI 2010 Poster 430.
  • 17
    Marzocchetti A, Tompkins T, Clifford DB et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009; 73: 15511558.
  • 18
    Tassie JM, Gasnault J, Bentata M et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS 1999; 13: 18811887.
  • 19
    Vlahakis SR, Bennet S, Whitehead S, Badley AD. HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo. Apoptosis 2007; 12: 969977.
  • 20
    Merabova N, Kaminski R, Krynska B, Amini S, Khalili K, Darbinyan A. JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons. J Cell Physiol 2012; 227: 31193127.